Treatment of panic disorder with bupropion in a patient with Parkinson’s disease
Summary We report on a 57‐year‐old woman, diagnosed with Parkinson’s disease, whose panic disorder showed marked improvement after introduction of bupropion, a norepinephrine–dopamine reuptake inhibitor. Additionally a comorbid major depression disappeared under this treatment. Bupropion may be usef...
Gespeichert in:
| Veröffentlicht in: | Journal of clinical pharmacy and therapeutics 2008-10, Vol.33 (5), p.575-577 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 577 |
|---|---|
| container_issue | 5 |
| container_start_page | 575 |
| container_title | Journal of clinical pharmacy and therapeutics |
| container_volume | 33 |
| creator | Gebhardt, S. Röttgers, H. Bäcker, A. Schu, U. Krieg, J.‐C. |
| description | Summary
We report on a 57‐year‐old woman, diagnosed with Parkinson’s disease, whose panic disorder showed marked improvement after introduction of bupropion, a norepinephrine–dopamine reuptake inhibitor. Additionally a comorbid major depression disappeared under this treatment. Bupropion may be useful for the treatment of patients with both panic disorder and Parkinson’s disease. |
| doi_str_mv | 10.1111/j.1365-2710.2008.00952.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69639164</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69639164</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4782-73cd71a95fc365e6a3da677098b5933d7b915678ad3067bfc36b33de68a1acc63</originalsourceid><addsrcrecordid>eNqNkEtOwzAQhi0EoqVwBZQN7BL8SOxkwQJVPFWJCpW1NXEc4ZImxU7Vdsc1uB4nwWmrsgRvbM18M_71IRQQHBF_rqYRYTwJqfAFinEaYZwlNFodoP6-cYj6mPIsjAUVPXTi3BRjzAVlx6hH0pTFTMR99DKxGtqZrtugKYM51EYFhXGNLbQNlqZ9C_LF3DZz09SBqQPwSGs6etMbg303tWvq788v181pcPoUHZVQOX22uwfo9e52MnwIR8_3j8ObUahikdJQMFUIAllSKh9Zc2AFcCFwluZJxlgh8owkXKRQMB8776jclzVPgYBSnA3Q5Xavz_ex0K6VM-OUriqodbNwkmecZYTHf4IUx5zHmHgw3YLKNs5ZXcq5NTOwa0mw7MTLqez8ys6v7MTLjXi58qPnuz8W-UwXv4M70x642AHgFFSlhVoZt-co5gknostwveWWptLrfweQT8PxxL_YD5GCn0I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20466401</pqid></control><display><type>article</type><title>Treatment of panic disorder with bupropion in a patient with Parkinson’s disease</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Gebhardt, S. ; Röttgers, H. ; Bäcker, A. ; Schu, U. ; Krieg, J.‐C.</creator><creatorcontrib>Gebhardt, S. ; Röttgers, H. ; Bäcker, A. ; Schu, U. ; Krieg, J.‐C.</creatorcontrib><description>Summary
We report on a 57‐year‐old woman, diagnosed with Parkinson’s disease, whose panic disorder showed marked improvement after introduction of bupropion, a norepinephrine–dopamine reuptake inhibitor. Additionally a comorbid major depression disappeared under this treatment. Bupropion may be useful for the treatment of patients with both panic disorder and Parkinson’s disease.</description><identifier>ISSN: 0269-4727</identifier><identifier>EISSN: 1365-2710</identifier><identifier>DOI: 10.1111/j.1365-2710.2008.00952.x</identifier><identifier>PMID: 18834374</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult and adolescent clinical studies ; Anxiety disorders. Neuroses ; Biological and medical sciences ; bupropion ; Bupropion - therapeutic use ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Depression ; Depressive Disorder, Major - complications ; Depressive Disorder, Major - drug therapy ; Dopamine Uptake Inhibitors - therapeutic use ; Female ; Humans ; Medical sciences ; Middle Aged ; Mood disorders ; Neurology ; Panic disorder ; Panic Disorder - complications ; Panic Disorder - drug therapy ; Parkinson Disease - complications ; Parkinson Disease - drug therapy ; Parkinson’s disease ; Pharmacology. Drug treatments ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry</subject><ispartof>Journal of clinical pharmacy and therapeutics, 2008-10, Vol.33 (5), p.575-577</ispartof><rights>2008 The Authors. Journal compilation © 2008 Blackwell Publishing Ltd</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4782-73cd71a95fc365e6a3da677098b5933d7b915678ad3067bfc36b33de68a1acc63</citedby><cites>FETCH-LOGICAL-c4782-73cd71a95fc365e6a3da677098b5933d7b915678ad3067bfc36b33de68a1acc63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2710.2008.00952.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2710.2008.00952.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27915,27916,45565,45566</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20656171$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18834374$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gebhardt, S.</creatorcontrib><creatorcontrib>Röttgers, H.</creatorcontrib><creatorcontrib>Bäcker, A.</creatorcontrib><creatorcontrib>Schu, U.</creatorcontrib><creatorcontrib>Krieg, J.‐C.</creatorcontrib><title>Treatment of panic disorder with bupropion in a patient with Parkinson’s disease</title><title>Journal of clinical pharmacy and therapeutics</title><addtitle>J Clin Pharm Ther</addtitle><description>Summary
We report on a 57‐year‐old woman, diagnosed with Parkinson’s disease, whose panic disorder showed marked improvement after introduction of bupropion, a norepinephrine–dopamine reuptake inhibitor. Additionally a comorbid major depression disappeared under this treatment. Bupropion may be useful for the treatment of patients with both panic disorder and Parkinson’s disease.</description><subject>Adult and adolescent clinical studies</subject><subject>Anxiety disorders. Neuroses</subject><subject>Biological and medical sciences</subject><subject>bupropion</subject><subject>Bupropion - therapeutic use</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Depression</subject><subject>Depressive Disorder, Major - complications</subject><subject>Depressive Disorder, Major - drug therapy</subject><subject>Dopamine Uptake Inhibitors - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mood disorders</subject><subject>Neurology</subject><subject>Panic disorder</subject><subject>Panic Disorder - complications</subject><subject>Panic Disorder - drug therapy</subject><subject>Parkinson Disease - complications</subject><subject>Parkinson Disease - drug therapy</subject><subject>Parkinson’s disease</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><issn>0269-4727</issn><issn>1365-2710</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEtOwzAQhi0EoqVwBZQN7BL8SOxkwQJVPFWJCpW1NXEc4ZImxU7Vdsc1uB4nwWmrsgRvbM18M_71IRQQHBF_rqYRYTwJqfAFinEaYZwlNFodoP6-cYj6mPIsjAUVPXTi3BRjzAVlx6hH0pTFTMR99DKxGtqZrtugKYM51EYFhXGNLbQNlqZ9C_LF3DZz09SBqQPwSGs6etMbg303tWvq788v181pcPoUHZVQOX22uwfo9e52MnwIR8_3j8ObUahikdJQMFUIAllSKh9Zc2AFcCFwluZJxlgh8owkXKRQMB8776jclzVPgYBSnA3Q5Xavz_ex0K6VM-OUriqodbNwkmecZYTHf4IUx5zHmHgw3YLKNs5ZXcq5NTOwa0mw7MTLqez8ys6v7MTLjXi58qPnuz8W-UwXv4M70x642AHgFFSlhVoZt-co5gknostwveWWptLrfweQT8PxxL_YD5GCn0I</recordid><startdate>200810</startdate><enddate>200810</enddate><creator>Gebhardt, S.</creator><creator>Röttgers, H.</creator><creator>Bäcker, A.</creator><creator>Schu, U.</creator><creator>Krieg, J.‐C.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>200810</creationdate><title>Treatment of panic disorder with bupropion in a patient with Parkinson’s disease</title><author>Gebhardt, S. ; Röttgers, H. ; Bäcker, A. ; Schu, U. ; Krieg, J.‐C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4782-73cd71a95fc365e6a3da677098b5933d7b915678ad3067bfc36b33de68a1acc63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult and adolescent clinical studies</topic><topic>Anxiety disorders. Neuroses</topic><topic>Biological and medical sciences</topic><topic>bupropion</topic><topic>Bupropion - therapeutic use</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Depression</topic><topic>Depressive Disorder, Major - complications</topic><topic>Depressive Disorder, Major - drug therapy</topic><topic>Dopamine Uptake Inhibitors - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mood disorders</topic><topic>Neurology</topic><topic>Panic disorder</topic><topic>Panic Disorder - complications</topic><topic>Panic Disorder - drug therapy</topic><topic>Parkinson Disease - complications</topic><topic>Parkinson Disease - drug therapy</topic><topic>Parkinson’s disease</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gebhardt, S.</creatorcontrib><creatorcontrib>Röttgers, H.</creatorcontrib><creatorcontrib>Bäcker, A.</creatorcontrib><creatorcontrib>Schu, U.</creatorcontrib><creatorcontrib>Krieg, J.‐C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical pharmacy and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gebhardt, S.</au><au>Röttgers, H.</au><au>Bäcker, A.</au><au>Schu, U.</au><au>Krieg, J.‐C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of panic disorder with bupropion in a patient with Parkinson’s disease</atitle><jtitle>Journal of clinical pharmacy and therapeutics</jtitle><addtitle>J Clin Pharm Ther</addtitle><date>2008-10</date><risdate>2008</risdate><volume>33</volume><issue>5</issue><spage>575</spage><epage>577</epage><pages>575-577</pages><issn>0269-4727</issn><eissn>1365-2710</eissn><abstract>Summary
We report on a 57‐year‐old woman, diagnosed with Parkinson’s disease, whose panic disorder showed marked improvement after introduction of bupropion, a norepinephrine–dopamine reuptake inhibitor. Additionally a comorbid major depression disappeared under this treatment. Bupropion may be useful for the treatment of patients with both panic disorder and Parkinson’s disease.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>18834374</pmid><doi>10.1111/j.1365-2710.2008.00952.x</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0269-4727 |
| ispartof | Journal of clinical pharmacy and therapeutics, 2008-10, Vol.33 (5), p.575-577 |
| issn | 0269-4727 1365-2710 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69639164 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Adult and adolescent clinical studies Anxiety disorders. Neuroses Biological and medical sciences bupropion Bupropion - therapeutic use Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Depression Depressive Disorder, Major - complications Depressive Disorder, Major - drug therapy Dopamine Uptake Inhibitors - therapeutic use Female Humans Medical sciences Middle Aged Mood disorders Neurology Panic disorder Panic Disorder - complications Panic Disorder - drug therapy Parkinson Disease - complications Parkinson Disease - drug therapy Parkinson’s disease Pharmacology. Drug treatments Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry |
| title | Treatment of panic disorder with bupropion in a patient with Parkinson’s disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T01%3A37%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20panic%20disorder%20with%20bupropion%20in%20a%20patient%20with%20Parkinson%E2%80%99s%20disease&rft.jtitle=Journal%20of%20clinical%20pharmacy%20and%20therapeutics&rft.au=Gebhardt,%20S.&rft.date=2008-10&rft.volume=33&rft.issue=5&rft.spage=575&rft.epage=577&rft.pages=575-577&rft.issn=0269-4727&rft.eissn=1365-2710&rft_id=info:doi/10.1111/j.1365-2710.2008.00952.x&rft_dat=%3Cproquest_cross%3E69639164%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20466401&rft_id=info:pmid/18834374&rfr_iscdi=true |